Heart Drug for Free Could Save Lives, Money
Study Shows Society Saves Money if Older Patients With Diabetes Get ACE Inhibitor Drugs for Free
July 18, 2005 -- Blood pressure-lowering ACE inhibitor drugs are among the best weapons available for preventing life-threatening complications in patients with diabetes, yet far too few of those patients take them.
Cost is believed to be a big deterrent to ACE inhibitor use, especially among older people who often have numerous chronic medical problems and take many other medications. Now a new study suggests that we would all save money if the 8 million people with diabetes in the U.S. over the age of 65 got the drugs for free.
Lowering blood pressure with medications has been shown to reduce the risk of heart disease, which is the major cause of death in people with diabetes. According to the American Diabetes Association, people with diabetes have a twofold to fourfold increase in the risk of dying from complications of heart disease.
Researchers concluded that giving ACE inhibitors to older people with diabetes would financially benefit the Medicare system and society at large. The blood pressure lowering drugs prevent costly heart attacks, strokes, and kidney failure in these high-risk patients. People with diabetes should be treated to attain a blood pressure of less than 130/80.
The cost analysis of the researchers was published in the July 19 issue of the Annals of Internal Medicine.
"Giving ACE inhibitors to older diabetics at no cost is really a win-win situation," researcher Allison B. Rosen, MD, MPH, tells WebMD. "Ensuring that the people who will benefit most are on the medications that will help save their lives is not just good for the patients, it is good for the bottom line in terms of getting the most value for our health care dollar."
Calculating the Costs
Rosen's research comes as federal officials are set to implement the Medicare prescription drug coverage plan, which will pay some of the drug costs for the elderly and disabled.
Even though ACE inhibitors are relatively cheap -- with generic versions of the drugs costing patients around $250 a year -- Rosen says study after study has shown that even small out-of-pocket expenses keep many people from taking the drugs they need.